These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1833977)
1. Hypertension, hypertrophy, and the occurrence of cardiovascular disease. Kannel WB Am J Med Sci; 1991 Oct; 302(4):199-204. PubMed ID: 1833977 [TBL] [Abstract][Full Text] [Related]
2. Left ventricular hypertrophy as a risk factor: the Framingham experience. Kannel WB J Hypertens Suppl; 1991 Dec; 9(2):S3-8; discussion S8-9. PubMed ID: 1838765 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Kannel WB Am J Med; 1983 Sep; 75(3A):4-11. PubMed ID: 6226193 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic implications of left ventricular hypertrophy in arterial hypertension]. Kannel WB Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583 [TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy and risk of cardiac failure: insights from the Framingham Study. Kannel WB; Levy D; Cupples LA J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S135-40. PubMed ID: 2485019 [TBL] [Abstract][Full Text] [Related]
7. Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies. Kannel WB J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S27-37. PubMed ID: 7692148 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy as a risk factor in arterial hypertension. Kannel WB Eur Heart J; 1992 Sep; 13 Suppl D():82-8. PubMed ID: 1396865 [TBL] [Abstract][Full Text] [Related]
9. Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death. Messerli FH; Soria F Am J Med; 1992 Aug; 93(2A):21S-26S. PubMed ID: 1387763 [TBL] [Abstract][Full Text] [Related]
10. Population implications of electrocardiographic left ventricular hypertrophy. Kannel WB; Dannenberg AL; Levy D Am J Cardiol; 1987 Dec; 60(17):85I-93I. PubMed ID: 2961250 [TBL] [Abstract][Full Text] [Related]
11. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B; JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161 [TBL] [Abstract][Full Text] [Related]
12. Hypertension: left ventricular hypertrophy, ventricular ectopy, and sudden death. Ketelhut R; Messerli FH Prim Care; 1991 Sep; 18(3):577-92. PubMed ID: 1835104 [TBL] [Abstract][Full Text] [Related]
19. Importance of left ventricular mass as a predictor of cardiovascular morbidity in hypertension. Devereux RB Am J Hypertens; 1989 Aug; 2(8):650-4. PubMed ID: 2528360 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular hypertrophy in hypertension. Dunn FG; Burns JM; Hornung RS Am Heart J; 1991 Jul; 122(1 Pt 2):312-5. PubMed ID: 1828935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]